Medicinal Chemistry is a dynamic, multifaceted scientific discipline that is dedicated to the improvement of human health through research that leads to the design and development of safe and effective therapeutic, diagnostic, and environmental agents.
Biosafety/ biosecurity, cancer and neurological drug discovery, chemical neuroscience, chemoprevention and carcinogenesis, combinatorial biosynthesis, computer-aided drug design, drug metabolism, gene therapy, high-throughput screening, immunology, NMR, non-hormonal contraception, peptidomimetics and X-ray crystallography.
Faculty Spotlight: Courtney Aldrich
Dr. Aldrich received a $3.8 million NIH grant for the project "Siderophore Inhibitors for Tuberculosis that Block Mycobactin Biosynthesis" on which he is the sole PI. Also, his collaborative research was the focus of a LA times article.
Faculty Spotlight: Natalia Tretyakova
Faculty Spotlight: Gunda Georg
The ITDD carries out interdisciplinary research, helps educate the next generation of scientists, and enhances the biomedical research infrastructure by creating opportunities for drug discovery and early pre-clinical drug development.
Congratulations to four of our graduate students who have been recognized by the National Science Foundation for their applications to the NSF Graduate Research Fellowship Program! Brandi McKnight (Doran lab) and Katherine Jones (Harki Lab, Chemistry) both received the 2019 GRFP award and Caroline Buchholz (Pomerantz lab) and Nicole Bentz (Wagner lab) received honorable mentions for their applications.
Congratulations to Dr. Daniel Harki who was awarded a 2019 American Association for Cancer Research Bayer Innovation and Discovery Grant! This grant is aimed at providing new treatment options for cancers with high unmet medical needs, encouraging innovation into the development of novel drugs, and fostering collaborations between academic groups and the pharmaceutical industry.
Congratulations to Drs. Philip Portoghese and Eyup Akgun, who were granted a patent in 2018 for their invention that provides analgesic conjugates useful for treating inflammatory pain associated with conditions like cancer, serious burns, and spinal injury. Click here to view their patent, "Highly Potent Analgesics for Inflammatory Pain."
Congratulations to Jian Tang of the Harki Lab who received a Department of Defense Peer Reviewed Cancer Research Program (PRCRP) Horizon Award! The award is a mentored training award for predoctoral trainees with a focus on promoting high-impact cancer research. The grant will fund Jian's research and supplies for his project “Targeting NF-kappaB-Inducing Kinase (NIK) for the Treatment of Hematologic Malignancies” for the next two years.
Make use of the Department's over 30,000 square feet of modern research laboratory space located within the Academic Health Center and the Biomedical Discovery District. Read more about our instrumentation, laboratories, facilities and facaulty research.